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Abstract
Background: Australian mortality rates are higher in regional and remote areas than in major cities. The degree to
which this is driven by variation in modifiable risk factors is unknown.
Methods: We applied a risk prediction equation incorporating smoking, cholesterol and blood pressure to a
national, population based survey to project all-causes mortality risk by geographic region. We then modelled life
expectancies at different levels of mortality risk by geographic region using a risk percentiles model. Finally we set
high values of each risk factor to a target level and modelled the subsequent shift in the population to lower
levels of mortality risk and longer life expectancy.
Results: Survival is poorer in both Inner Regional and Outer Regional/Remote areas compared to Major Cities for
men and women at both high and low levels of predicted mortality risk. For men smoking, high cholesterol and
high systolic blood pressure were each associated with the mortality difference between Major Cities and Outer
Regional/Remote areas–accounting for 21.4%, 20.3% and 7.7% of the difference respectively. For women smoking
and high cholesterol accounted for 29.4% and 24.0% of the difference respectively but high blood pressure did not
contribute to the observed mortality differences. The three risk factors taken together accounted for 45.4% (men)
and 35.6% (women) of the mortality difference. The contribution of risk factors to the corresponding differences for
inner regional areas was smaller, with only high cholesterol and smoking contributing to the difference in men–
accounting for 8.8% and 6.3% respectively– and only smoking contributing to the difference in women–
accounting for 12.3%.
Conclusions: These results suggest that health intervention programs aimed at smoking, blood pressure and total
cholesterol could have a substantial impact on mortality inequities for Outer Regional/Remote areas.
Background
Mortality rates in Australia are higher in rural and
remote areas than major cities. In 2002-04, death rates
for males in Inner Regional, Outer Regional, Remote
and Very Remote areas were significantly higher than
their counterparts in Major Cities, with standardised
mortality ratios (SMR) of 1.1, 1.2, 1.2 and 1.7 respec-
tively. Females in these areas also had significantly
higher death rates, with SMRs of 1.1, 1.1, 1.2 and 1.7
respectively [1]. This could be due to a range of influ-
ences including lower socioeconomic status, poorer risk
factor profiles, differential access to health services and
the high proportion of Indigenous people in these areas
[1-3]. Research in other countries has shown that the
drivers of geographic variation in mortality include soci-
etal and economic factors but that individual health risk
factors play a significant role [4-7].
The Australian Human Rights Commission identified
rural health inequities as a substantial human rights
issue for Australia [8]. Reduction of risk factor preva-
lence across regions may be one way to address these
inequities, but the potential of this approach is
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unknown. Here we examine the extent to which varia-
tion in life expectancy between Australian geographic
regions is associated with variations in selected modifi-
able risk factors. We adapt a previously developed cor-
onary heart disease model developed for the Australian
population to analyse the potential impact of changing
the prevalence of smoking, high cholesterol and high
blood pressure on life expectancy in the Major City,
Inner Regional and combined Outer Regional/Remote
regions in Australia [9].
Methods
We used a mortality risk prediction equation applied to
a national population survey to model percentiles of
short-term mortality risk by geographic region. We then
modelled survival curves and associated life expectancies
for each percentile of risk. Finally we modelled the effect
of each risk factor by setting high values of that factor
to a ‘target’ level and modelling the subsequent popula-
tion shift to lower percentiles of mortality risk and asso-
ciated longer life expectancy.
Geographic regions
This study used the Australian Standard Geographical
Classification (ASGC), which groups geographic areas
into five regions–defined using an index of the remote-
ness of a location from the services provided by large
towns or cities. The regions are Major City, Inner
Regional, Outer Regional, Remote and Very Remote
[10]. The Major City region contains urban centres with
a population greater than 250,000. Conversely the Very
Remote region is defined to contain the most remote
one per cent of the population while the Remote and
Very Remote regions together contain the most remote
three per cent of the population. According to the 2001
Australian population census, the Inner Regional regions
together contained 3,872,693 people, the Outer Regional
regions together contained 1,978,495 people, the Remote
regions together contained 334,683 people and the Very
Remote regions together contained 201,120 people [1].
Our study used three regions–Major City, Inner
Regional and a combined Outer Regional/Remote group.
Data sources
The AusDiab study
Our national population survey was the baseline survey
of the Australian Diabetes, Obesity and Lifestyle (Aus-
Diab) study [11]. This was a cross-sectional, national,
population-based survey of 11,247 adults aged ≥ 25
years in 1999-2000, comprising a household interview
and biomedical examination at a testing site. Among the
information collected was seated systolic and diastolic
blood pressure; self-reported cigarette smoking status;
and serum total cholesterol. Of the 11,247 survey
participants 8,706 were aged 40 or over. Of these 8,534
had complete data for systolic and diastolic blood pres-
sure; self-reported cigarette smoking status; and serum
total cholesterol–3,880 male and 4,654 female.
Because of small numbers we grouped the oldest Aus-
Diab participants into one group aged 75 years and
over. The percentile scores for this group were taken to
apply equally to the age groups 75-79, 80-84 and 85
years and over.
The number of AusDiab participants in Major Cities,
Inner and Outer Regional and Remote areas aged 40
and over and the number with complete risk factor data
for systolic and diastolic blood pressure; self-reported
cigarette smoking status; and serum total cholesterol are
given in Table 1. There were no AusDiab collection cen-
tres in Very Remote areas and only one collection cen-
tre in a Remote area, so we excluded Very Remote areas
and combined the Outer Regional and Remote areas.
National population and death counts
National population and death counts classified by age,
sex and geographic region for 2001 - 2006 were supplied
by the Australian Institute of Health and Welfare
(AIHW). The population counts were derived from the
Australian Bureau of Statistics (ABS) mid-year popula-
tion estimates. Deaths data were derived from the
AIHW National Mortality Database comprising all
deaths registered in Australia.
Availability of data
The AusDiab confidentialised unit record data are avail-
able for serious scientific research proposals that are
consistent with the overall AusDiab program of research
activities; that do not conflict with work in progress;
and where the interests and personal privacy of survey
subjects are protected and Institutional Ethics Commit-
tee approval has been given for the proposed research.
Access to the data is decided by the AusDiab Scientific
Research Committee on the basis of a written
application.
National population and death counts classified by age
and sex are freely available from the AIHW web-site.
However, data with more detailed classifications, such as
the regional classifications used here, are available on
written application from a researcher provided they are
aggregated to levels where there is no potential for iden-
tification of data for individuals. Where such specific
tabulations are requested, the AIHW charges a fee
based on full-cost recovery for any programming and
other costs associated with the planning, extraction and
provision of the data.
Risk prediction equation
The basis of the categorisation of mortality risk into
percentiles was a risk prediction equation for cardiovas-
cular disease mortality using modifiable health risk
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factors. We used an index developed by the SCORE
(Systematic COronary Risk Evaluation) project [12].
This project assembled a pooled dataset of cohort stu-
dies from 12 European countries and derived a risk pre-
diction equation for risk of death from cardiovascular
disease. The pooled data set comprised 88,080 women
and 117,098 men and the risk was predicted for ages 45
- 64. The equation was calculated separately for men
and women and incorporated age as the basis of the
hazard function. The variables in this equation are:
smoking status, total cholesterol and systolic blood pres-
sure (SBP).
To assess the suitability of the SCORE statistic as a
proxy for short-term all-cause mortality risk for our
study we followed a similar method to Aktas et al [13].
The baseline AusDiab sample has been followed up for
subsequent death via a regular linking with Australian
death registry data, commencing with a follow-up to
2004 and then followed up annually with the most
recent linkage being for 2008 [14]. We predicted the
risk of death using a Cox proportional hazards regres-
sion equation with the SCORE statistic as a predictor
variable and death from any cause up to 1 June 2004 as
the outcome variable. Follow-up to 2004 was chosen
rather than follow-up to 2008 because the model uses
the SCORE statistic to allocate short-term mortality.
The model was fitted separately for men and women
and included age categorised into five year age groups
as a covariate. SCORE was originally derived to predict
risk at ages 45 - 64, but our study applies to ages 40
and over. So we fitted the Cox regression to ages 40 and
over to demonstrate SCORE’s overall ability to predict
all cause mortality risk and we fitted a separate regres-
sion to ages 65 and over to demonstrate its predictive
ability at older ages. We used the adjusted Hosmer-
Lemeshow goodness of fit statistic and the Harrell’s C
statistic to assess the regression equations’ fit and pre-
dictive ability [15,16].
The risk percentiles model
A summary of the modelling methods is presented here.
A detailed description of these methods is included in
the additional file 1: appendix.
The risk percentiles model was used to derive an aver-
age life expectancy at each percentile of projected mor-
tality risk based on the SCORE equation. The Australian
disease burden associated with the modifiable risk fac-
tors incorporated in our risk prediction equation is very
small below age 40, so our modelling was applied to
ages 40 and over [17]. The steps involved in the calcula-
tion, within each age, sex and regional group, are as fol-
lows [9]:
Table 1 AusDiab sample counts and number with complete data for blood pressure; self-reported cigarette smoking
status; and serum total cholesterol in each region for respondents aged 40 and over by age and sex
Region
Age Major city Inner regional Outer regional Total
Sample count Complete data Sample count Complete data Sample count Complete data Sample count Complete data
Males
40-45 242 240 147 144 208 203 597 587
45-49 270 267 176 176 217 209 663 652
50-54 314 310 171 170 197 194 682 674
55-59 248 245 121 115 129 126 498 486
60-64 210 206 107 104 112 111 429 421
65-69 206 201 91 88 101 100 398 389
70-74 138 133 106 100 89 85 333 318
75 and over 186 181 86 84 90 88 362 353
Total 1,814 1,783 1,005 981 1,143 1,116 3,962 3,880
Females
40-45 357 349 212 206 244 244 813 799
45-49 351 341 223 220 229 227 803 788
50-54 346 339 196 193 201 196 743 728
55-59 296 291 142 138 171 170 609 599
60-64 263 260 105 104 120 118 488 482
65-69 185 184 125 120 126 125 436 429
70-74 192 189 110 105 99 97 401 391
75 and over 219 215 115 108 117 115 451 438
Total 2,209 2,168 1,228 1,194 1,307 1,292 4,744 4,654
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1. Divide the Australian population into mortality risk
percentiles.
The SCORE equation was applied to the AusDiab data
to calculate the five-year probability of death for each
individual in the survey (their risk score). Survey weights
were applied to the survey sample so that the data could
be taken as estimates for the total Australian population
and the values of the risk score that divide the weighted
sample into percentiles were then calculated. Each sur-
vey participant was allocated to a risk percentile using
their risk score and a total risk score for all participants
calculated for each percentile.
2. Allocate deaths to risk percentiles.
The national count of deaths summed across 2001 -
2006 was allocated to the risk percentiles using the
ratios of the aggregate risk score between percentiles.
For example, if one percentile group had a total risk
score twice that of another group then the deaths were
allocated between them in the ratio 2 - 1. When divided
by the population count summed across 2001 - 2006
(assumed evenly spread between risk percentiles) this
gives us the death rate for each risk percentile group.
3. Use these mortality rates to construct sex-specific
life tables and survival curves for each risk percentile
within each regional group.
After step 2, we had a set of age specific mortality
rates by sex for each percentile group within each
region. We applied standard life table techniques [18]
using these mortality rates to construct a sex-specific
life table for each percentile group within each region.
We used these life tables to generate sex-specific survi-
val curves and life expectancies for each percentile
group within each region.
Modelling the effect of risk factors on inter-regional
mortality differentials
The effect of risk factors on inter-regional mortality dif-
ferentials was modelled for the 2006 Australian popula-
tion. For each age-sex-region group, the modelled life
expectancy at each percentile of projected mortality risk
as derived above was multiplied by the corresponding
2006 population count to obtain the projected total life
years for each group. This was summed over the per-
centiles and ages within each region and divided by the
regional population count to calculate a baseline average
potential years of life (APYL) per person for each region.
The risk factors modelled in this paper were those in
the SCORE equation which are potentially modifiable–
smoking, total cholesterol and systolic blood pressure
[12]. We returned to the AusDiab survey data to model
the effect of setting high values of each risk factor sepa-
rately to a ‘target’ value. For example, in examining
blood pressure each survey participant with a SBP
greater than or equal to 140 mmHg had his/her risk
score recalculated assuming a SBP of 120–creating a
synthetic sample of people with SBP below high risk
levels. The participants were reallocated to the risk per-
centiles using the existing risk score cut offs with their
revised risk score values. This, when weighted using the
AusDiab survey weights, provided a modelled estimate
of the shift in the total Australian population between
each percentile group under this scenario. Note that this
does not imply that any practical intervention would be
capable of reducing blood pressure to a target level for
all people with high blood pressure. The aim of the
model is to investigate a theoretical impact of blood
pressure reduction by comparing the mortality out-
comes associated with the current population with those
projected for a population where no one has a blood
pressure above the target value.
We multiplied the existing average life expectancy for
each percentile-age-sex-region group by the new popu-
lation count projected to be in that group under each
scenario. This was summed over the percentiles and
ages within each region and divided by the regional
population count to calculate a scenario average poten-
tial years of life per person for each region.
This procedure is illustrated in Table 2 with a
hypothetical population of 100,000 people divided into
risk quartiles (not percentiles) for ease of presentation.
Column 2 presents the number of people in each quar-
tile at baseline and column 3 is the average life expec-
tancy from our model for each quartile. Column 4
presents the baseline lifeyears estimate, which is calcu-
lated by multiplying column 2 by column 3. If we sum
column 4 and divide this by the total population, we get
the baseline APYL per person (32.5 years). Column 5
presents the number of people allocated to each quartile
after the survey participants have had their risk adjusted
as described above. Column 6 represents the scenario
lifeyears estimate and is calculated by multiplying col-
umn 3 by column 5. If we sum column 6 and divide
this by the total population, we get the scenario APYL
per person (35.0 years).
The high risk values for SBP and total cholesterol
were 140 mmHg and 5.5 mmol/l respectively [19]. The
target values for SBP and total cholesterol were the tar-
get levels published by the Australian National Heart
Foundation (NHF)–120 mmHg and 4 mmol/l respec-
tively [20,21]. For smoking the ‘target’ was taken as the
absence of smoking, so the risk equations were recalcu-
lated with current smokers changed to non-smokers.
The population prevalence of each risk factor above its
target level was estimated by calculating the correspond-
ing proportion from the AusDiab survey weighted using
the survey weights.
The risk factor prevalence estimates and the baseline
and scenario potential life years per person estimates
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were age-standardised using the Major City population
as the standard population. This allowed direct compari-
sons between geographic regions.
Calculations of the proportions of risk and of people
in each percentile group were based on relatively small
numbers in some region, age, and sex groups leading to
excessive variability in the resulting proportions. Thus,
we applied a LOESS non-parametric smoothing proce-
dure to the proportions [22]. We used bootstrapping to
construct confidence intervals for all estimates presented
in this paper with the exception of those arising from
the Cox proportion hazards regression models, where
standard errors and confidence intervals were generated
by the regression modelling procedure [23]. The model-
ling, smoothing and regression calculations were con-
ducted using SAS statistical software (SAS version 9.1.3.
SAS Institute Inc.).
Results
Risk factor prevalence
Table 3 gives the estimated age-standardised proportion
of people with high risk factor value in the Australian
population by geographic region, and the standardised
prevalence ratio (SPR) between Major Cities and each
other region.
The highest proportion was for cholesterol, with more
than 50% of the population having a high cholesterol
value for both sexes in each region–ranging from 53.2%
(95%CI: 50.2%- 56.4%) in men in Major Cities to 61.1%
(95%CI: 55.7%-66.1%) also in men but in the combined
Outer Regional/Remote region.
For men, the prevalence of smoking and high choles-
terol rose between Major Cities and Inner Regional
areas and rose even further in Outer Regional/Remote
areas, though the confidence intervals suggest that the
differences were only statistically significant in the
Outer Regional/Remote areas. The SPR values for cho-
lesterol between Major Cities and Inner Regional and
Outer Regional/Remote Areas were 1.03 (95%CI: 0.92-
1.12) and 1.15 (95%CI: 1.01-1.27) respectively. The cor-
responding SPR values for smoking were 1.04 (95%CI:
0.80-1.37) and 1.38 (95%CI: 1.06-1.83). The prevalence
of high SBP fell between Major Cities and Inner Regio-
nal areas but rose again in Outer Regional/Remote
areas. However the SPR values all had confidence inter-
vals containing 1–suggesting that none of the differ-
ences was statistically significant.
For women, the prevalence of smoking showed a simi-
lar pattern to that for men with SPR values of 1.22 (95%
CI: 0.92-1.67) and 1.39 (95%CI: 1.00-1.90). The preva-
lence of high cholesterol fell between Major Cities and
Inner Regional areas but rose again in Outer Regional/
Remote areas. The prevalence of high SBP fell between
Major Cities and Inner Regional areas and remained low
in Outer Regional/Remote areas. The SPR values for
both cholesterol and SBP had confidence intervals con-
taining 1–suggesting that none of the differences was
statistically significant.
The SCORE equation as a predictor of all causes mortality
There were 246 deaths prior to 1 June 2004 among the
8,534 survey participants included in our modelling–154
men and 92 women. Of those participants aged 65 and
over, there were 191 deaths–116 men and 75 women.
The results of fitting the Cox proportional hazards
regression model to predict all-cause mortality using the
SCORE index as a predictor variable are given in Tables
4, 5, 6 and 7. The SCORE index is a strongly significant
predictor of mortality for ages 40 and over for both men
and women (p = 0.012 for men and p = 0.0037 for
women). The adjusted Hosmer-Lemeshow goodness of
fit statistic shows no evidence of lack of fit in either equa-
tion (c2 value 6.58, p = 0.68 for men and c2 value 9.37, p
= 0.40 for women) and the C statistics show good predic-
tive power with values of 83% for men and 84% for
women–C values above 80% are generally regarded as
demonstrating excellent predictive power [24].
The SCORE index is still a strong predictor of mortal-
ity when the regression is restricted to ages 65 and over
(p = 0.018 for men and p = 0.0036 for women). The
adjusted Hosmer-Lemeshow goodness of fit statistic
shows no evidence of lack of fit in either equation (c2
value 12.00, p = 0.21 for men and c2 value 16.11, p =
0.06 for women) and the C statistics show reasonable
predictive power with values of 67% for men and 71%
for women.
A similar analysis with follow-up of death to 2008 was
also done to test the sensitivity of the conclusions to the
Table 2 Modelling the impact of a risk factor illustrated with a hypothetical population
Quartile of risk Baseline population distribution Average life expectancy Baseline PYL Scenario population distribution Scenario PYL
1 25,000 40 1,000,000 40,000 1,600,000
2 25,000 35 875,000 30,000 1,050,000
3 25,000 30 750,000 20,000 600,000
4 25,000 25 625,000 10,000 250,000
Total 100,000 3,250,000 100,000 3,500,000
APYL 32.5 35.0
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choice of follow-up date (results not shown). The
SCORE statistic also performed well as a predictor of
all-cause mortality with this follow-up date.
Modelled regional life expectancy
The survival curves and associated life expectancies were
calculated separately for each age-sex-region-percentile
group. However, for ease of presentation, we have illu-
strated the results of this modelling by presenting them
at age 40 for the highest and lowest deciles of projected
mortality risk.
Figures 1 and 2 present the number per 100,000 from
the life table surviving at each age over 40 for the lowest
and highest deciles of predicted mortality risk by region.
Survival is better for women than men in each region at
each risk level. Survival is also better in Major Cities
than Outer Regional/Remote areas for men and women
at each risk level.
Figures 3 and 4 present life expectancies at age 40
years for the lowest and highest deciles of mortality risk
in each region. For men in both low and high risk
groups, there is a relatively steady fall in life expectancy
across the Major City, Inner Regional and Outer Regio-
nal/Remote areas. The life expectancy difference
between Major Cities and Outer Regional/Remote areas
was 3.1 years for the low-risk group (95%CI: -0.9, 5.9)
and 2.3 years for the high-risk group (95%CI: 1.8, 2.8)
(data not shown).
Table 3 Prevalence of high values of risk factors by geographic region, age standardised
Major City Inner Regional Outer Regional/Remote
Males
Smoker Prevalence 14.2% (11.7%, 16.2%) 14.8% (11.1%, 17.9%) 19.6% (15.2%, 24.5%)
SPR 1 1.04 (0.74, 1.35) 1.38 (1.06, 1.93)
Cholesterol Prevalence 53.2% (49.8%, 55.7%) 54.7% (50.2%, 59.0%) 61.1% (56.1%, 65.5%)
SPR 1 1.03 (0.92, 1.12) 1.15 (1.01, 1.27)
Systolic blood pressure Prevalence 32.6% (29.9%, 35.9%) 30.6% (26.8%, 34.4%) 38.0% (32.7%, 43.5%)
SPR 1 0.94 (0.84, 1.18) 1.17 (0.91, 1.28)
Females
Smoker Prevalence 9.3% (7.6%, 11.2%) 11.4% (8.5%, 14.0%) 13.0% (9.5%, 15.9%)
SPR 1 1.22 (0.89, 1.63) 1.39 (1.00, 1.90)
Cholesterol Prevalence 56.3% (53.1%, 59.6%) 55.8% (51.9%, 59.6%) 60.6% (55.7%, 64.7%)
SPR 1 0.99 (0.91, 1.09) 1.08 (0.97, 1.18)
Systolic blood pressure Prevalence 27.4% (24.7%, 30.1%) 27.2% (23.8%, 30.8%) 26.1% (22.1%, 30.4%)
SPR 1 0.99 (0.75, 1.22) 0.95 (0.76, 1.26)
Notes
1. Proportion of the Australian population at ages 40 and over with high values of risk factors by geographic region, age standardised.
2. Prevalence estimated from AusDiab survey with 95% confidence intervals in brackets.
3. Age standardised prevalence rates and Standardised Prevalence Ratios (SPR) calculated using Major City population as the standard population.
4. The high risk values for systolic blood pressure and total cholesterol were 140 mmHg and 5.5 m mol/l respectively
Table 4 Results of Cox proportional hazards regression model, males aged 40 and over
Parameter DF Estimate Standard Error Chi-Square Pr > ChiSq Hazard Ratio 95% confidence limits
Score 1 1.58 0.63 6.29 0.0121 4.83 1.41 16.55
Age 40-44 1 -4.31 1.03 17.58 < .0001 0.01 0.00 0.10
Age 45-49 1 -2.35 0.42 31.09 < .0001 0.10 0.04 0.22
Age 50-54 1 -3.10 0.55 31.99 < .0001 0.05 0.02 0.13
Age 55-59 1 -1.99 0.39 25.54 < .0001 0.14 0.06 0.30
Age 60-64 1 -1.29 0.32 16.57 < .0001 0.28 0.15 0.51
Age 65-69 1 -1.02 0.28 13.18 0.0003 0.36 0.21 0.63
Age 70-74 1 -0.53 0.24 5.11 0.0238 0.59 0.37 0.93
Adjusted Hosmer-Lemeshow goodness of fit
Chi-Square DF Pr > ChiSq
6.58 8 0.68
Notes
1. Results of a Cox proportional hazards regression model predicting risk of death prior to 1 June 2004 among male AusDiab participants aged 40 and over
2. Age group 75 and over taken as baseline group for the age parameter
C statistic: 83%
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For women at low risk, there is no consistent pattern
in life expectancy between the Major City, Inner and
Outer Regional/Remote areas–with life expectancy fall-
ing between Major Cities and Inner Regional areas but
rising again between Inner and Outer Regional areas.
Women at high risk are more similar to their male
counterparts in having a relatively steady fall in life
expectancy across the Major City, Inner and Outer
Regional/Remote areas. The difference in female life
expectancy for those in the high risk group between
Major Cities and Outer Regional/Remote areas is 2.0
years (95%CI: 1.5, 2.3) (data not shown).
The effect of modifiable risk factors on average potential
years of life (APYL) in each region
Table 8 presents the APYL per person (age standar-
dised) for the Australian population in 2006 by sex and
region for the baseline and each risk factor target sce-
nario and for all three risk factor scenarios together, and
the differences in APYL between the baseline and each
scenario.
Setting high values of each risk factor to its target
increases the APYL in each region. The risk factor asso-
ciated with the largest rise in APYL across all regions
was high cholesterol for both men and women–with an
increase in APYL of between 2.5 and 3.0 years for men
and between 2.4 and 3.0 years for women. Setting all
three risk factors together to no higher than their target
levels led to an increase in APYL of between 6.0 and 7.3
years for men and 6.1 and 7.1 years for women. The
increase was greatest in Outer Regional/Remote areas
for each risk factor except for SBP in women, where the
Major City and Outer Regional/Remote increases were
equal.
The effect of setting each risk factor to its target on
the difference in APYL between Major Cities and each
other region largely followed the prevalence distribution
(Table 9). For men the prevalence of smoking and high
cholesterol rose by a small amount between Major
Cities and Inner Regional areas and rose again by a lar-
ger amount in Outer Regional areas. The prevalence of
high SBP fell between Major Cities and Inner Regional
Table 5 Results of Cox proportional hazards regression model, females aged 40 and over
Parameter DF Estimate Standard Error Chi-Square Pr > ChiSq Hazard Ratio 95% confidence limits
score 1 2.32 0.80 8.42 0.0037 10.20 2.13 48.95
Age 40-44 1 -3.23 0.75 18.41 <.0001 0.04 0.01 0.17
Age 45-49 1 -2.80 0.63 19.72 <.0001 0.06 0.02 0.21
Age 50-54 1 -2.22 0.51 18.81 <.0001 0.11 0.04 0.30
Age 55-59 1 -2.55 0.63 16.57 <.0001 0.08 0.02 0.27
Age 60-64 1 -2.09 0.55 14.27 0.0002 0.12 0.04 0.37
Age 65-69 1 -1.35 0.42 10.50 0.0012 0.26 0.12 0.59
Age 70-74 1 -0.27 0.28 0.90 0.3433 0.76 0.44 1.33
Adjusted Hosmer-Lemeshow goodness of fit
Chi-Square DF Pr > ChiSq
9.37 8 0.40
Notes
1. Results of a Cox proportional hazards regression model predicting risk of death prior to 1 June 2004 among female AusDiab participants aged 40 and over
2. Age group 75 and over taken as baseline group for the age parameter
C statistic: 84%
Table 6 Results of Cox proportional hazards regression model, males aged 65 and over
Parameter DF Estimate Standard Error Chi-Square Pr > ChiSq Hazard Ratio 95% confidence limits
score 1 1.51 0.64 5.59 0.0181 4.54 1.30 15.94
Age 65-69 1 -1.03 0.28 13.51 0.0002 0.36 0.21 0.62
Age 70-74 1 -0.54 0.24 5.24 0.022 0.58 0.37 0.93
Adjusted Hosmer-Lemeshow goodness of fit
Chi-Square DF Pr > ChiSq
12.00 8 0.21
Notes
1. Results of a Cox proportional hazards regression model predicting risk of death prior to 1 June 2004 among male AusDiab participants aged 65 and over
2. Age group 75 and over taken as baseline group for the age parameter
C statistic: 67%
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areas but rose again in Outer Regional areas. Accord-
ingly eliminating smoking and high cholesterol was
associated with a decrease in the APYL differential
between Major Cities and Inner Regional areas (by 6.3%
and 8.8% respectively). Eliminating high values of each
of the three risk factors separately (smoking, cholesterol
and SBP) was associated with a decrease in the APYL
differences between Major Cities and Outer Regional/
Remote areas by 21.4%, 20.3% and 7.7% respectively.
Overall the elimination of high values of cholesterol and
SBP and the elimination of smoking together was asso-
ciated with a fall in the differential between Major Cities
and Outer Regional/Remote areas (by 45.4%) but not
with a fall in the differential between Major Cities and
Inner Regional areas.
For women, with the exception of smoking, the preva-
lence of high risk factor values fell between Major Cities
and Inner Regional areas. The prevalence of smoking
and high cholesterol rose between Major Cities and
Outer Regional/Remote areas but the prevalence of high
SBP in Outer Regional/Remote areas remained below
that of Major Cities. Accordingly smoking was the only
risk factor whose elimination was associated with a
decrease in the APYL differential between Major Cities
and Inner Regional areas (by 12.3%) while eliminating
each of smoking and high cholesterol was associated
Table 7 Results of Cox proportional hazards regression model, females aged 65 and over
Parameter DF Estimate Standard Error Chi-Square Pr > ChiSq Hazard Ratio 95% confidence limits
score 1 2.34 0.80 8.49 0.0036 10.33 2.15 49.67
Age 65-69 1 -1.35 0.42 10.48 0.0012 0.26 0.12 0.59
Age 70-74 1 -0.27 0.28 0.89 0.3465 0.77 0.44 1.34
Adjusted Hosmer-Lemeshow goodness of fit
Chi-Square DF Pr > ChiSq
16.11 8 0.06
Notes
1. Results of a Cox proportional hazards regression model predicting risk of death prior to 1 June 2004 among female AusDiab participants aged 65 and over
2. Age group 75 and over taken as baseline group for the age parameter
C statistic: 71%
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Table 8 APYL per person at age 40 by geographic region for selected risk factor scenarios
Major city Inner regional Outer regional/remote
Males Years (95% CI) Years (95% CI) Years (95% CI)
Baseline 29.4 (29.1, 29.8) 27.9 (27.6, 28.3) 27.0 (26.7, 27.8)
Total cholesterol < 5.5 31.9 (31.4, 32.5) 30.5 (29.7, 31.3) 30.0 (29.2, 31.3)
SBP < 140 31.6 (31.0, 32.1) 29.8 (29.2, 30.7) 29.4 (28.9, 30.6)
No smoking 30.4 (30.1, 30.8) 29.0 (28.6, 29.4) 28.6 (28.2, 29.4)
1-3 combined 35.7 (34.7, 36.6) 33.9 (32.9, 35.4) 34.4 (32.8, 36.5)
Females Years (95% CI) Years (95% CI) Years (95% CI)
Baseline 32.9 (32.3, 33.5) 31.5 (30.7, 32.2) 31.1 (30.4, 32.0)
Total cholesterol < 5.5 35.4 (34.5, 36.5) 33.9 (32.7, 35.6) 34.1 (32.9, 35.3)
SBP < 140 35.4 (34.5, 36.5) 33.8 (32.4, 34.9) 33.6 (32.3, 35.3)
No smoking 33.8 (33.3, 34.7) 32.6 (32.1, 33.3) 32.6 (31.9, 33.4)
1-3 combined 39.3 (38.0, 40.7) 37.5 (36.2, 39.4) 38.2 (36.2, 40.4)
Difference from baseline
Males Years (95% CI) Years (95% CI) Years (95% CI)
Total cholesterol < 5.5 2.5 (1.8, 3.2) 2.6 (1.7, 3.5) 3.0 (1.7, 4.2)
SBP < 140 2.2 (1.5, 2.9) 1.9 (1.0, 2.7) 2.4 (1.3, 3.4)
No smoking 1.0 (0.5, 1.5) 1.1 (0.6, 1.7) 1.5 (0.7, 2.3)
1-3 combined 6.3 (5.2, 7.3) 6.0 (4.6, 7.3) 7.3 (5.4, 9.3)
Females Years (95% CI) Years (95% CI) Years (95% CI)
Total cholesterol < 5.5 2.6 (1.4, 3.7) 2.4 (0.8, 4.1) 3.0 (1.5, 4.5)
SBP < 140 2.5 (1.3, 3.7) 2.3 (0.9, 3.7) 2.5 (0.8, 4.2)
No smoking 1.0 (0.0, 1.9) 1.1 (0.2, 2.1) 1.5 (0.4, 2.6)
1-3 combined 6.4 (5.0, 7.9) 6.1 (4.4, 7.8) 7.1 (4.8, 9.3)
Note: Age standardised APYL calculated using Major City population as the standard population
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with a decrease in the differential between Major Cities
and Outer Regional/Remote areas (by 29.4% and 20.4%
respectively). Overall the elimination of high values of
cholesterol and SBP and the elimination of smoking
together was associated with a fall in the differential
between Major Cities and Outer Regional/Remote areas
(by 35.6%) but not with a fall in the differential between
Major Cities and Inner Regional areas.
Discussion
Eliminating smoking and setting high values of total
cholesterol and SBP to their recommended target levels
increased average potential years of life per person by
between 6.0 and 7.3 years for men and 6.1 and 7.1 years
for women. The increase was greatest in Outer Regio-
nal/Remote areas for all risk factors except for SBP in
women, where the Major City increase was equal to the
Outer Regional/Remote area increase.
Mortality differences between regions affect men at all
risk levels but mainly apply to higher risk women. Elimi-
nating smoking would reduce mortality differences
between Major Cities and each other region for both
men and women. In addition, reducing high cholesterol
would reduce mortality differences between Major Cities
and each other region for men. Reducing high choles-
terol in women or high SBP in men would reduce the
mortality difference between Major Cities and Outer
Regional/Remote areas but not Inner Regional areas.
The combined effect of reducing high cholesterol and
high SBP and eliminating smoking would reduce the
APYL difference between Major Cities and Outer Regio-
nal/Remote areas by 45.4% for men and 35.6% for
women.
Previous research has found a complex relationship
between geographic variation in risk factors and mortal-
ity. Papastergiou and colleagues found that low eco-
nomic activity and access to health services were
significant drivers of regional variation in all-cause mor-
tality in Greece [4]. Romeri and colleagues studied
regional variation in mortality in England and Wales
and found that while mortality increased with depriva-
tion, the relationship was strongest for smoking-related
causes–suggesting an unmeasured role for smoking [5].
Men et al. analysed regional trends in Russian mortality
and concluded that fluctuations in mortality correlated
strongly with underlying economic and societal factors
but that risk factors (particularly alcohol) played a part
at an individual level [6]. Bassuk and colleagues studied
Table 9 Difference in APYL per person at age 40 between major cities and other regions
Inner regional Outer regional/remote
Males Years (95% CI) Years (95% CI)
Baseline 1.5 (0.9, 1.9) 2.4 (1.7, 2.9)
Total cholesterol < 5.5 1.4 (0.6, 2.4) 1.9 (0.4, 3.2)
SBP < 140 1.8 (1.0, 2.6) 2.2 (1.1, 3.0)
No smoking 1.4 (0.9, 2.0) 1.9 (1.0, 2.3)
1-3 combined 1.8 (-0.1, 3.4) 1.3 (-1.2, 3.1)
Females Years (95% CI) Years (95% CI)
Baseline 1.4 (0.5, 2.7) 1.7 (0.9, 2.6)
Total cholesterol < 5.5 1.5 (-0.3, 2.9) 1.3 (-0.3, 3.1)
SBP < 140 1.6 (0.4, 3.4) 1.7 (-0.3, 3.5)
No smoking 1.2 (0.3, 2.2) 1.2 (0.2, 2.2)
1-3 combined 1.8 (-0.8, 3.5) 1.1 (-1.6, 4.0)
% difference associated with each risk factor
Males
Total cholesterol < 5.5 8.8% 20.3%
SBP < 140 -21.0% 7.7%
No smoking 6.3% 21.4%
1-3 combined -19.6% 45.4%
Females
Total cholesterol < 5.5 -9.8% 24.0%
SBP < 140 -11.9% -0.1%
No smoking 12.3% 29.4%
1-3 combined -26.7% 35.6%
Notes
1. Age standardised APYL calculated using Major City population as the standard population
2. Negative proportions indicate cells where APYL difference increased for the risk factor scenario
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mortality in the elderly in four US communities and
concluded that while individual characteristics such as
health risk factors played a role, it was also important to
consider community attributes that mediate or modify
the pathways through which socioeconomic conditions
may influence health [7]. Our study provides quantifica-
tion in the Australian population of the effect of indivi-
dual risk factors. However, as noted by the researchers
quoted here, the individual risk factors must be viewed
in the context of broader societal and economic influ-
ences. Hence, while our study did not address health
services, societal and economic factors, these broader
factors may be the principal drivers of regional mortality
differentials while the health risk factors may act as
mediators.
The WHO Comparative Risk Assessment project
developed methods for comparing the disease burden
attributable to different health risk factors in a standar-
dised way. These methods are based on the use of popu-
lation attributable fractions (PAF) with a consistent
theoretical framework that uses the ‘hypothetical mini-
mum’ as the counterfactual against which burden due to
a risk is calculated. They also include continuous risk
variables accounting for the full range of risk from ele-
vated blood pressure and serum cholesterol, rather than
defining thresholds for hypertension and hypercholester-
olaemia [25]. These methods have been used to develop
estimates of the Australian disease burden for the major
health risk factors [17]. In principle, these methods
could be used to model the difference in burden
between regions by examining differences in risk factor
prevalence and inferring differences in disease burden.
However, our methods have the strength of directly
modelling the absolute effects of specific risk factors on
the inter-regional difference in all-cause mortality. PAF’s
are typically derived for specific causes of death and so
would require separate modelling for each cause related
to each risk factor and then aggregating across different
causes. Our methods do, however, have the limitation of
using risk factor threshold values rather than using the
whole risk factor distribution. This may lead to an
underestimate of the health impact of the risk factor
and hence a conservative estimate of its impact on
inter-regional mortality differences.
The major strength of our modelling approach is the
ability to apportion mortality to percentiles of mortality
risk based on measured rather than self-reported choles-
terol and blood pressure values and total population and
mortality counts. This allows us to model the effect of
changing risk factor profiles on the distribution of risk
within the population.
One limitation of our study is the use of the SCORE
equation as a proxy for all-causes mortality risk. Our
study requires an all-causes mortality risk prediction
equation based on the modifiable risk factors measured
in our population based sample. Our literature search
found two such equations in the literature which could
potentially be suitable for application to our population
survey data–one based on the Multiple Risk Factor
Intervention Trial (MRFIT) study developed by Kannel
et al. [26] and one based on the Aerobics Center Longi-
tudinal Study at the Cooper Clinic in Dallas, Texas (the
Cooper Clinic Mortality Risk Index) developed by Jans-
sen et al. [27]. However, both of these equations were
developed for men only and we need to be able to apply
our risk equation to both men and women. Further, the
MRFIT equation used diastolic blood pressure as its
blood pressure measure rather than the more commonly
used systolic blood pressure and the Cooper Clinic
index incorporated an exercise stress test of cardiore-
spiratory fitness which was not available in our popula-
tion based sample. So neither equation was suitable for
our study.
Cardiovascular disease is the leading cause of death
in Australia–comprising 34% of all deaths registered in
2008 [28]. Further, tobacco smoking as well as being a
leading risk factor for cardiovascular disease (CVD) is
also a leading risk factor for death from a wide range
of other causes [7]. This suggests that a cardiovascular
mortality risk prediction equation incorporating
tobacco use among its predictor variables such as the
SCORE index may be a suitable proxy for an all-causes
mortality risk prediction equation. Aktas et al. exam-
ined the SCORE equation as a predictor of all cause
mortality risk in a sample of 3,554 asymptomatic
adults (2871 men and 683 women) aged 50 - 75 years
at the Cleveland Clinic Foundation in Cleveland, Ohio
[3]. They found that the SCORE index was strongly
predictive of all-cause mortality in their sample.
Further, they found that SCORE was a considerably
better predictor of all-cause mortality than the Fra-
mingham risk score, which is the other most com-
monly used CVD risk score. We used a similar
approach to Aktas et al. in using a Cox proportional
hazards regression model to predict all-cause mortality
within our population based sample with the SCORE
as the predictor variable. Our Cox regression analysis
showed that the SCORE index was a good predictor of
all-causes mortality for both men and women at ages
40 and over and at ages 65 and over. The original
SCORE index was derived for men and women aged
45 - 64. Our regression for people aged 40 and over
supports our use of the SCORE index as a proxy for
all-cause mortality risk in our risk percentiles model.
Our regression for people aged 65 and over demon-
strates that the SCORE index can be used as a proxy
for all-causes mortality risk at older ages than the ori-
ginal group for which it was derived.
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Another limitation is that the AusDiab survey partici-
pants are known to have lower mortality risk than the
general Australian population, despite being drawn from
a population-based random sample. However, our study
relies on the ordering of risk within the population
rather than the absolute level of risk and so should be
relatively robust to this limitation.
A further limitation is that our study excludes Very
Remote areas and does not provide separate results for
Remote areas. This is a limitation of a population based
modelling approach as less than three per cent of the
Australian population live in Remote and Very Remote
areas. Hence the numbers of people and of deaths are
too small in these areas to support separate estimates
using our modelling approach.
The study is limited to those risk factors incorporated
in the SCORE risk prediction equation–smoking, blood
pressure and cholesterol. Tobacco and blood pressure
are the two leading risk factors associated with disease
burden in Australia and cholesterol is the fifth (after
obesity and physical inactivity), so these risk factors are
appropriate for this study [17]. The exclusion of other
risk factors renders our study results conservative in
estimating the total contribution of modifiable risk fac-
tors to life expectancy differentials. Further work in this
area would benefit from developing an all-causes mor-
tality risk prediction equation incorporating further risk
factors.
Our study is an ‘ecological’ study in that it only exam-
ines risk factor prevalence at the regional level and
hence neglects the distribution of risk factors and life
expectancy within these regions. This may also lead to
underestimation of the contribution of the risk factors
to the mortality differential.
Our modelling is aimed at quantifying the contribu-
tion of modifiable health risk factors to regional mortal-
ity differentials. Hence our estimates represent an upper
bound to the gains that could be made from interven-
tions targeting these risk factors rather than a projection
of the actual gains from any specific health promotion
activity. However, they do demonstrate that there are
potentially substantial gains in health equity which
could arise from addressing modifiable health risk fac-
tors in outer regional and remote areas.
Conclusions
Australian mortality rates are higher in regional and
remote areas than in major cities and the associated
health inequities have been identified as significant
human rights issues for Australia [8]. Our results sug-
gest that health intervention programs aimed at smok-
ing, blood pressure and total cholesterol could have a
substantial impact on mortality inequities at least for
Outer Regional/Remote areas.
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